Citadel Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Buy |
518,887
+516,382
| +20,614% | +$22.5M | ﹤0.01% | 891 |
|
|
2025
Q1 | $68.6K | Sell |
2,505
-56,062
| -96% | -$1.53M | ﹤0.01% | 5273 |
|
|
2024
Q4 | $2.36M | Sell |
58,567
-2,765
| -5% | -$111K | ﹤0.01% | 2438 |
|
|
2024
Q3 | $2.9M | Sell |
61,332
-92,325
| -60% | -$4.37M | ﹤0.01% | 2189 |
|
|
2024
Q2 | $4.59M | Sell |
153,657
-107,724
| -41% | -$3.22M | ﹤0.01% | 1753 |
|
|
2024
Q1 | $10.5M | Sell |
261,381
-110,062
| -30% | -$4.42M | ﹤0.01% | 1266 |
|
|
2023
Q4 | $9.46M | Buy |
371,443
+152,460
| +70% | +$3.88M | ﹤0.01% | 1264 |
|
|
2023
Q3 | $3.04M | Sell |
218,983
-60,599
| -22% | -$842K | ﹤0.01% | 2016 |
|
|
2023
Q2 | $6.43M | Buy |
279,582
+279,364
| +128,149% | +$6.42M | ﹤0.01% | 1525 |
|
|
2023
Q1 | $6.46K | Sell |
218
-27,791
| -99% | -$823K | ﹤0.01% | 5588 |
|
|
2022
Q4 | $699K | Sell |
28,009
-23,610
| -46% | -$589K | ﹤0.01% | 3544 |
|
|
2022
Q3 | $1.12M | Buy |
+51,619
| New | +$1.12M | ﹤0.01% | 3301 |
|
|
2022
Q2 | – | Sell |
-74,658
| Closed | -$3.16M | – | 6525 |
|
|
2022
Q1 | $3.16M | Buy |
74,658
+40,860
| +121% | +$1.73M | ﹤0.01% | 2498 |
|
|
2021
Q4 | $2.15M | Sell |
33,798
-80,130
| -70% | -$5.09M | ﹤0.01% | 2977 |
|
|
2021
Q3 | $6.69M | Buy |
113,928
+51,440
| +82% | +$3.02M | ﹤0.01% | 1791 |
|
|
2021
Q2 | $3.03M | Sell |
62,488
-62,237
| -50% | -$3.02M | ﹤0.01% | 2739 |
|
|
2021
Q1 | $4.85M | Buy |
+124,725
| New | +$4.85M | ﹤0.01% | 2134 |
|